Maternal Metabolic Health and Mother and Baby Health Outcomes (MAMBO): Protocol of a Prospective Observational Study.

ABSTRACT:

Background

Metabolic disease is increasingly impacting women of reproductive age. In pregnancy, uncontrolled metabolic disease can result in offspring with major congenital anomalies, preterm birth, and abnormal fetal growth. Pregnancy also accelerates the complications of metabolic diseases in mothers resulting in an increased risk of premature cardiovascular events. Despite the convincing evidence that preconception care can largely mitigate the risks of metabolic disease in pregnancy, there are few data about how to identify the highest-risk women so that they can be connected with appropriate preconception care services.

Objective

The aim of the study is to determine the maternal phenotype that represents the highest risk of having adverse neonatal and maternal pregnancy

SUBMITTER: Price SAL 

PROVIDER: S-EPMC12032496 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature